Advances in functional neurosurgery for Parkinson's disease

Movement Disorders

Volumn 30, Issue 11, 2015, Pages 1461-1470

  Metman, Leo Verhagen ^a   Slavin, Konstantin V ^b  

^a RUSH MEDICAL COLLEGE   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Closed loop; Current steering; DBS; Focused ultrasound; Frameless; Functional neurosurgery; Gene therapy; Intra operative CT; Intra operative MRI; Parkinson; Surgery

Indexed keywords

AROMATIC LEVO AMINO ACID DECARBOXYLASE; CYCLOHYDROLASE 1; DOPAMINE; GENE THERAPY AGENT; HYDROLASE; LEVODOPA; NEURTURIN; PARVOVIRUS VECTOR; PROSAVIN; TYROSINE 3 MONOOXYGENASE; UNCLASSIFIED DRUG;

BRADYKINESIA; BRAIN COMPUTER INTERFACE; BRAIN DEPTH STIMULATION; CLOSED LOOP DEEP BRAIN STIMULATION SYSTEM; COMPUTER ASSISTED TOMOGRAPHY; DISEASE DURATION; DOPAMINE RELEASE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; ELECTRODE IMPLANT; ELECTRODE IMPLANTATION; ELECTROMYOGRAPHY; ESSENTIAL TREMOR; FRAMELESS STEREOTACTIC PROCEDURE; HIGH INTENSITY FOCUSED ULTRASOUND; HUMAN; INTERVENTIONAL MAGNETIC RESONANCE IMAGING; INTRAOPERATIVE COMPUTER ASSISTED TOMOGRAPHY; NERVE STIMULATOR; NEUROSURGERY; NUCLEAR MAGNETIC RESONANCE SCANNER; OUTCOME ASSESSMENT; PARKINSON DISEASE; PATIENT SAFETY; PEDUNCULOPONTINE TEGMENTAL NUCLEUS; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PSYCHOLOGICAL WELL BEING; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; STEREOTACTIC DEVICE; STEREOTACTIC RADIOSURGERY; SUBTHALAMIC NUCLEUS; SURGICAL APPROACH; SURGICAL TECHNIQUE; UNIFIED PARKINSON DISEASE RATING SCALE; VIRAL GENE THERAPY; BRAIN; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSIOLOGY; PROCEDURES;

BRAIN; DEEP BRAIN STIMULATION; HUMANS; MAGNETIC RESONANCE IMAGING; NEUROSURGICAL PROCEDURES; PARKINSON DISEASE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84941599648     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.26338     Document Type: Review

References (66)

1. Schuepbach WM, Rau J, Knudson K, et al. Neurostimulation for Parkinson's disease with early motor complications. N Engl J Med 2013;368:610-622.
2. Charles D, Konrad PE, Neimat JS, et al. Subthalamic nucleus deep brain stimulation in early stage Parkinson's disease. Parkinsonism Relat Disord 2014;20:731-737.
3. Camalier CR, Konrad PE, Gill CE, et al. Methods for surgical targeting of the STN in early-stage Parkinson's disease. Front Neurol 2014;5:1-6.
4. Tramontana MG, Molinari AL, Konrad PE, et al. Neuropsychological effects of deep brain stimulation in subjects with early stage Parkinson's disease in a randomized clinical trial. J Parkinsons Dis 2015;5:151-163.
5. Follett KA, Weaver FM, Stern M, et al. Pallidal versus subthalamic deep-brain stimulation for Parkinson's disease. N Engl J Med 2010;362:2077-2091.
6. Weaver FM, Follett KA, Stern M, et al. Randomized trial of deep brain stimulation for Parkinson's disease: thirty-six-month outcomes. Neurology 2012;79:55-65.
7. Odekerken VJJ, van Laar T, Staal MJ, et al. Subthalamic nucleus versus globus pallidus bilateral deep brain stimulation for advanced Parkinson's disease (NSTAPS study): a randomized controlled trial. Lancet Neurol 2013;12:37-44.
8. Odekerken VJ, Boel JA, Geurtsen GJ, et al.; The NSTAPS Study Group. Neuropsychological outcome after deep brain stimulation for Parkinson disease. Neurology 2015;84:1355-1361.
9. Deuschl G, Schade-Brittinger C, Krack P, et al. A randomized trial of deep-brain stimulation for Parkinson's disease. N Engl J Med 2006;355:896-908.
10. Limousin P, Krack P, Pollak P, et al. Electrical stimulation of the subthalamic nucleus in advanced Parkinson's disease. N Engl J Med 1998;339:1105-1111.
11. Morita H, Hass CJ, Moro E, Sudhyadhom A, Kumar R, Okun MS. Pedunculopontine nucleus stimulation: where are we now and what needs to be done to move the field forward? Front Neurol 2014;5:243.
12. Mazzone P, Paoloni M, Mangone M, Santilli V, Insola A, Fini M, Scarnati E. Unilateral deep brain stimulation of the pedunculopontine tegmental nucleus in idiopathic Parkinson's disease: effects on gait initiation and performance. Gait Posture 2014;40:357-362.
13. Mazzone P, Sposato S, Insola A, Scarnati E. The clinical effects of deep brain stimulation of the pedunculopontine tegmental nucleus in movement disorders may not be related to the anatomical target, leads location, and setup of electrical stimulation. Neurosurgery 2013;73:894-906.
14. Weiss PH, Herzog J, Pötter-Nerger M, et al. Subthalamic nucleus stimulation improves parkinsonian gait via brainstem locomotor centers. Mov Disord 2015 Apr 25. doi: 10.1002/mds.26229. [Epub ahead of print]
15. Starr PA, Martin AJ, Ostrem JL, Talke P, Levesque N, Larson PS. Subthalamic nucleus deep brain stimulator placement using high-field interventional magnetic resonance imaging and a skull-mounted aiming device: technique and application accuracy. J Neurosurg 2010;112:479-490.
16. Chabardes S, Isnard S, Castrioto A, Oddoux M, Fraix V, Carlucci L, et al. Surgical implantation of STN-DBS leads using intraoperative MRI guidance: technique, accuracy, and clinical benefit at 1-year follow-up. Acta Neurochir (Wien) 2015;157:729-737.
17. Sillay KA, Rusy D, Buyan-Dent L, Ninman NL, Vigen KK. Wide-bore 1.5 T MRI-guided deep brain stimulation surgery: initial experience and technique comparison. Clin Neurol Neurosurg 2014;127:79-85.
18. Aviles-Olmos I, Kefalopoulou Z, Tripoliti E, et al. Long-term outcome of subthalamic nucleus deep brain stimulation for Parkinson's disease using an MRI-guided and MRI-verified approach. J Neurol Neurosurg Psychiatry 2014;85:1419-1425.
19. Ostrem JL, Galifianakis NB, Markun LC, et al. Clinical outcomes of PD patients having bilateral STN DBS using high-field interventional MR-imaging for lead placement. Clin Neurol Neurosurg 2013;115:708-712.
20. Ivan ME, Yarlagadda J, Saxena AP, Martin AJ, Starr PA, Sootsman WK, Larson PS. Brain shift during bur hole-based procedures using interventional MRI. J Neurosurg 2014;121:149-160.
21. Ostrem JL, Ziman N, Galifianakis N, et al. Clinical outcomes using Clearpoint interventional MRI for DBS lead placement in Parkinson's disease. J Neurosurg 2015 (in press).
22. Smith AP, Bakay RA. Frameless deep brain stimulation using intraoperative O-arm technology. J Neurosurg 2011;115:301-309.
23. Mirzadeh Z, Chapple K, Lambert M, Dhall R, Ponce FA. Validation of CT-MRI fusion for intraoperative assessment of stereotactic accuracy in DBS surgery. Mov Disord 2014;29:1788-1795.
24. Burchiel KJ, McCartney S, Lee A, et al. Accuracy of deep brain stimulation electrode placement using intraoperative computed tomography without microelectrode recording. J Neurosurg 2013;119:301-306.
25. Bot M, van den Munckhof P, Bakay RA, et al. Analysis of stereotactic accuracy in patients undergoing deep brain stimulation using Nexframe and Leksell frame. Stereotact Funct Neurosurg 2015 (in press).
26. Cheng CY, Hsing MT, Chen YH, et al. Deep brain stimulation for Parkinson's disease using frameless technology. Br J Neurosurg 2014;28:383-386.
27. Sharma M, Rhiew R, Deogaonkar M, et al. Accuracy and precision of targeting using frameless stereotactic system in deep brain stimulator implantation surgery. Neurol India 2014;62:503-509.
28. Miocinovic S, Khemani P, Whiddon R, Zeilman P, Martinez-Ramirez D, Okun MS, Chitnis S. Outcomes, management, and potential mechanisms of interleaving deep brain stimulation settings. Parkinsonism Relat Disord 2014;20:1434-1437.
29. Wojtecki L, Vesper J, Schnitzler A. Interleaving programming of subthalamic deep brain stimulation to reduce side effects with good motor outcome in a patient with Parkinson's disease. Parkinsons Relat Disord 2011;17:293-294.
30. Baumann CR, Imbach LL, Baumann-Vogel H, et al. Interleaving deep bain stimulation for a patient with both Parkinson's disease and essential tremor. Mov Disord 2012;27:1700-1701.
31. Kovács N, Janszky J, Nagy F, Balás I. Changing to interleaving stimulation might improve dystonia in cases not responding to pallidal stimulation. Mov Disord 2012;27:163-165.
32. Barbe MT, Dembek TA, Becker J, et al. Individualized current-shaping reduces DBS-induced dysarthria in patients with essential tremor. Neurology 2014;82:614-619.
33. Barbe MT, Maarouf M, Alesch F, Timmermann L. Multiple source current steering-a novel deep brain stimulation concept for customized programming in a Parkinson's disease patient. Parkinsonism Relat Disord 2014;20:471-473.
34. Contarino MF, Bour LJ, Verhagen R, Lourens MA, de Bie RM, van den Munckhof P, Schuurman PR. Directional steering: a novel approach to deep brain stimulation. Neurology 2014;83:1163-1169.
35. Schuurman PR, Contarino MF, Bour LJ, de Bie RM, van den Munckhof P. Steering deep brain stimulation: an exploratory study with a new 32-contact lead. Stereotact Funct Neurosurg 2013;91(Suppl 1):86.
36. Bour LJ, Lourens MA, Verhagen R, de Bie RM, van den Munckhof P, Schuurman PR, Contarino MF. Directional recording of subthalamic spectral power densities in Parkinson's disease and the effect of steering deep brain stimulation. Brain Stimul 2015 Feb 13. pii: S1935-861X(15)00882-7. doi:10.1016/j.brs.2015.02.002. [Epub ahead of print]
37. Pollo C, Kaelin-Lang A, Oertel MF, et al. Directional deep brain stimulation: an intraoperative double-blind pilot study. Brain 2014;137:2015-2026.
38. Xie T, Vigil J, MacCracken E, et al. Low-frequency stimulation of STN-DBS reduces aspiration and freezing of gait in patients with PD. Neurology 2015;84:415-420.
39. Vallabhajosula S, Haq IU, Hwynn N, Oyama G, Okun M, Tillman MD, Hass CJ. Low-frequency versus high-frequency subthalamic nucleus deep brain stimulation on postural control and gait in Parkinson's disease: a quantitative study. Brain Stimul 2015;8:64-75.
40. Vercruysse S, Vandenberghe W, Münks L, Nuttin B, Devos H, Nieuwboer A. Effects of deep brain stimulation of the subthalamic nucleus on freezing of gait in Parkinson's disease: a prospective controlled study. J Neurol Neurosurg Psychiatry 2014;85:871-877.
41. Huang H, Watts RL, Montgomery EB, Jr. Effects of deep brain stimulation frequency on bradykinesia of Parkinson's disease. Mov Disord 2014;29:203-206.
42. Reich MM, Steigerwald F, Sawalhe AD, et al. Short pulse width widens the therapeutic window of subthalamic neurostimulation. Ann Clin Transl Neurol 2015;2:427-432.
43. Seeger-Armbruster S, Bosch-Bouju C, Little ST, Smither RA, Hughes SM, Hyland BI, Parr-Brownlie LC. Patterned, but not tonic, optogenetic stimulation in motor thalamus improves reaching in acute drug-induced parkinsonian rats. J Neurosci 2015;35:1211-1216.
44. Brocker DT, Swan BD, Turner DA, et al. Improved efficacy of temporally non-regular deep brain stimulation in Parkinson's disease. Exp Neurol 2013;239:60-67.
45. Sun FT, Morrell MJ. Closed-loop neurostimulation: the clinical experience. Neurotherapeutics 2014;11:553-563.
46. Priori A, Foffani G, Rossi L, Marceglia S. Adaptive deep brain stimulation (aDBS) controlled by local field potential oscillations. Exp Neurol 2013;245:77-86.
47. Hebb AO, Zhang JJ, Mahoor MH, Tsiokos C, Matlack C, Chizeck HJ, Pouratian N. Creating the feedback loop: closed-loop neurostimulation. Neurosurg Clin N Am 2014;25:187-204.
48. Beuter A, Lefaucheur JP, Modolo J. Closed-loop cortical neuromodulation in Parkinson's disease: An alternative to deep brain stimulation? Clin Neurophysiol 2014;125:874-885.
49. Kühn AA, Tsui A, Aziz T, et al. Pathological synchronisation in the subthalamic nucleus of patients with Parkinson's disease relates to both bradykinesia and rigidity. Exp Neurol 2009;215:380-387.
50. Beudel M, Little S, Pogosyan A, et al. Tremor reduction by deep brain stimulation is associated with gamma power suppression in Parkinson's disease. Neuromodulation 2015;18:349-354.
51. Giannicola G, Rosa M, Marceglia S, et al. The effects of levodopa and deep brain stimulation on subthalamic local field low-frequency oscillations in Parkinson's disease. Neurosignals 2013;21:89-98.
52. Little S, Pogosyan A, Neal S, et al. Adaptive deep brain stimulation in advanced Parkinson's disease. Ann Neurol 2013;74:449-457.
53. Rosin B, Slovik M, Mitelman R, et al. Closed-loop deep brain stimulation is superior in ameliorating parkinsonism. Neuron 2011;72:370-384.
54. Lee KH, Chang SY, Robert DW, et al. Neurotransmitter release from high frequency stimulation of the subthalamic nucleus. J Neurosurg 2004;101:511-517.
55. Chang SY, Kimble CJ, Kim I, et al. Development of the Mayo Investigational Neuromodulation Control System: toward a closed-loop electrochemical feedback system for deep brain stimulation. J Neurosurg 2013;119:1556-1565.
56. Grahn PJ, Mallory GW, Khurram OU, et al. A neurochemical closed-loop controller for deep brain stimulation: toward individualized smart neuromodulation therapies. Front Neurosci 2014;8:169.
57. Basu I, Graupe D, Tuninetti D, Shukla P, Slavin KV, Metman LV, Corcos DM. Pathological tremor prediction using surface electromyogram and acceleration: potential use in 'ON-OFF' demand driven deep brain stimulator design. J Neural Eng 2013;10:036019.
58. Graupe D, Tuninetti D, Slavin KV, Basu I. Closed-loop electrochemical feedback system for DBS. J Neurosurg 2014;121:762-763.
59. Dobrakowski PP, Machowska-Majchrzak AK, Labuz-Roszak B, Majchrzak KG, Kluczewska E, Pierzchała KB. MR-guided focused ultrasound: a new generation treatment of Parkinson's disease, essential tremor and neuropathic pain. Interv Neuroradiol 2014;20:275-282.
60. Bauer R, Martin E, Haegele-Link S, Kaegi G, von Specht M, Werner B. Noninvasive functional neurosurgery using transcranial MR imaging-guided focused ultrasound. Parkinsonism Relat Disord 2014;20(Suppl 1):S197-S199
61. Elias WJ, Huss D, Voss T, et al. A pilot study of focused ultrasound thalamotomy for essential tremor. N Engl J Med 2013;369:640-648.
62. Magara A, Bühler R, Moser D, Kowalski M, Pourtehrani P, Jeanmonod D. First experience with MR-guided focused ultrasound in the treatment of Parkinson's disease. J Ther Ultrasound 2014;2:11.
63. Marks WJ, Ostrem JL, Verhagen L, et al. Gene transfer of a trophic factor for Parkinson's disease: initial clinical trial with AAV2-neurturin (CERE-120). Lancet Neurol 2008;7:400-408.
64. Marks W, Bartus R, Siffert J, et al. Double-blind, sham-surgery controlled trial of gene delivery of AAV2-neurturin for Parkinson's disease. Lancet Neurol 2010;9:1164-1172.
65. Olanow CW, Bartus RT, Baumann T, et al. Gene delivery of neurturin to putamen and substantia nigra in Parkinson's disease; a double-blind, randomized, controlled trial. Ann Neurol 2015 Jun 10. doi: 10.1002/ana.24436. [Epub ahead of print]
66. Palfi S, Gurruchaga JM, Ralph GS, et al. Long-term safety and tolerability of ProSavin, a lentiviral vector-based gene therapy for Parkinson's disease: a dose escalation, open-label, phase 1/2 trial. Lancet 2014;383:1138-1146.